Literature DB >> 3883968

Effect of epsilon-aminocaproic acid on postvitrectomy hemorrhage.

S de Bustros, B M Glaser, R G Michels, C Auer.   

Abstract

We performed a prospective study involving 96 patients undergoing vitrectomy for proliferative diabetic retinopathy to determine the effect of epsilon-aminocaproic acid on the occurrence of postoperative intraocular hemorrhage. epsilon-Aminocaproic acid significantly reduced postoperative vitreous hemorrhage during the immediate postoperative period. Follow-up examinations two to six weeks after discharge from the hospital disclosed no statistically significant difference in the severity of vitreous hemorrhage between the treated and untreated groups. The loss of drug effect at this stage was in part due to spontaneous repeated bleeding in the treated group and in part to spontaneous clearing of hemorrhage in the untreated group. There was no statistically significant difference in the rate of repeated bleeding between the two groups or in rate of spontaneous clearing.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3883968     DOI: 10.1001/archopht.1985.01050020071023

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  8 in total

1.  Intravitreal injection of bevacizumab and triamcinolone acetonide at the end of vitrectomy for diabetic vitreous hemorrhage: a comparative study.

Authors:  Dong Ho Park; Jae Pil Shin; Si Yeol Kim
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-12       Impact factor: 3.117

2.  A disposable system for rapid purification of autologous plasmin as an adjunct to vitrectomy - performance and safety profile.

Authors:  Martin Hermel; Wendelin Dailey; Michael Trese; Michael K Hartzer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-03       Impact factor: 3.117

3.  Effect of tranexamic acid on early postvitrectomy diabetic haemorrhage; a randomised clinical trial.

Authors:  A R Ramezani; H Ahmadieh; A K Ghaseminejad; S Yazdani; B Golestan
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

4.  Intravitreal bevacizumab as an adjunctive therapy before diabetic vitrectomy.

Authors:  Ashraf M El-Batarny
Journal:  Clin Ophthalmol       Date:  2008-12

5.  Effect of tranexamic acid on postvitrectomy haemorrhage in diabetic patients.

Authors:  L Laatikainen; P Summanen; I Immonen
Journal:  Int Ophthalmol       Date:  1987-06       Impact factor: 2.031

6.  Sulfur Hexafluoride 20% versus Lactated Ringer's Solution for Prevention of Early Postoperative Vitreous Hemorrhage after Diabetic Vitrectomy.

Authors:  Fereydoun Farrahi; Mostafa Feghhi; Biuk Bagherzadeh; Mahmood Latifi
Journal:  J Ophthalmic Vis Res       Date:  2010-04

7.  The adjunctive use of pre-operative intravitreal bevacizumab in the setting of proliferative diabetic retinopathy.

Authors:  Abdullah Al-Kharashi; Tural Galbinur; Efrem D Mandelcorn; Rajeev H Muni; Mir Nabavi; Peter J Kertes
Journal:  Saudi J Ophthalmol       Date:  2016-10-29

8.  The effect of adjunctive intravitreal conbercept at the end of diabetic vitrectomy for the prevention of post-vitrectomy hemorrhage in patients with severe proliferative diabetic retinopathy: a prospective, randomized pilot study.

Authors:  Tingting Jiang; Junxiang Gu; Peijun Zhang; Wenwen Chen; Qing Chang
Journal:  BMC Ophthalmol       Date:  2020-02-03       Impact factor: 2.209

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.